These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9269826)
1. The clinicopathological characteristics of gonadotroph cell adenoma: a study of 118 cases. Ho DM; Hsu CY; Ting LT; Chiang H Hum Pathol; 1997 Aug; 28(8):905-11. PubMed ID: 9269826 [TBL] [Abstract][Full Text] [Related]
2. Blood serum concentrations of gonadotropins and α-subunit in patients with gonadotropinomas in relation to the immunoreactivity of pituitary adenoma. Pawlikowski Łódź M; Jaranowska M; Fryczak J; Radek M; Świętosławski J; Kunert-Radek J; Winczyk K Endokrynol Pol; 2018; 69(5):526-529. PubMed ID: 30074232 [TBL] [Abstract][Full Text] [Related]
3. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas. Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365 [TBL] [Abstract][Full Text] [Related]
4. Inhibin and follicle-stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumour volume in men. Lahlou N; Le Nestour E; Chanson P; Seret-Bégué D; Bouchard P; Roger M; Warnet A Clin Endocrinol (Oxf); 1993 Mar; 38(3):301-9. PubMed ID: 8458102 [TBL] [Abstract][Full Text] [Related]
5. Application of catalyzed signal amplification in immunodetection of gonadotropin subunits in clinically nonfunctioning pituitary adenomas. Sanno N; Teramoto A; Sugiyama M; Itoh Y; Osamura RY Am J Clin Pathol; 1996 Jul; 106(1):16-21. PubMed ID: 8701926 [TBL] [Abstract][Full Text] [Related]
6. Gonadotroph adenoma with secondary hypersecretion of testosterone. Chamoun R; Layfield L; Couldwell WT World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183 [TBL] [Abstract][Full Text] [Related]
7. Expression of Pit-1 mRNA and activin/inhibin subunits in clinically nonfunctioning pituitary adenomas. In situ hybridization and immunohistochemical analysis. Sanno N; Teramoto A; Sugiyama M; Matsuno A; Takumi I; Tahara S; Osamura RY Horm Res; 1998; 50(1):11-7. PubMed ID: 9691207 [TBL] [Abstract][Full Text] [Related]
8. Gonadotroph cell adenomas of the pituitary. Snyder PJ Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559 [TBL] [Abstract][Full Text] [Related]
9. [Two cases of non-functional gonadotroph adenoma pituitary apoplexy following GnRH-agonist treatment revealing gonadotroph adenoma and pseudopituitary apoplexy after GnRH administration]. Hernandez Morin N; Huet D; Hautecouverture M Ann Endocrinol (Paris); 2003 Jun; 64(3):227-31. PubMed ID: 12910066 [TBL] [Abstract][Full Text] [Related]
11. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A; Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794 [TBL] [Abstract][Full Text] [Related]
12. [Value and limitations of the LHRH test in patients with amenorrhea-galactorrhea]. Bruno M; Campagnoli C; Gilli V; Mansueto MG; Olivieri A Minerva Ginecol; 1980 May; 32(5):364-7. PubMed ID: 6771721 [No Abstract] [Full Text] [Related]
13. Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomas. Chanson P; Lahlou N; Warnet A; Roger M; Sassolas G; Lubetzi J; Schaison G; Bouchard P J Endocrinol Invest; 1994 Feb; 17(2):91-8. PubMed ID: 8006338 [TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas. Friend KE; Chiou YK; Lopes MB; Laws ER; Hughes KM; Shupnik MA J Clin Endocrinol Metab; 1994 Jun; 78(6):1497-504. PubMed ID: 7515390 [TBL] [Abstract][Full Text] [Related]
15. Pituitary gonadotroph adenomas in old Sprague-Dawley rats. McComb DJ; Kovacs K; Beri J; Zak F; Milligan JV; Shin SH J Submicrosc Cytol; 1985 Oct; 17(4):517-30. PubMed ID: 3935810 [TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical and ultrastructural study of a follicle-stimulating hormone-secreting gonadotroph adenoma occurring in a 10-year-old girl. Tashiro H; Katabuchi H; Ohtake H; Yoshioka A; Matsumura S; Suenaga Y; Nagamura Y; Matsuura K; Okamura H Med Electron Microsc; 2000; 33(1):25-31. PubMed ID: 11810454 [TBL] [Abstract][Full Text] [Related]
18. Functional pituitary gonadotroph adenoma in male patients: Case report. Ram N; Khan SA; Das B; Islam N J Pak Med Assoc; 2022 Aug; 72(8):1652-1655. PubMed ID: 36280939 [TBL] [Abstract][Full Text] [Related]
19. TRH is a tonic secretagogue in growth hormone secreting but not in nonfunctioning pituitary tumors. Somjen D; Tordjman K; Greenman Y; Kohen F; Ouaknine GE; Stern N J Endocrinol Invest; 1999 Feb; 22(2):104-8. PubMed ID: 10195376 [TBL] [Abstract][Full Text] [Related]
20. Histologic and immunohistochemical study of clinically non-functioning pituitary adenomas: special reference to gonadotropin-positive adenomas. Sano T; Yamada S Pathol Int; 1994 Sep; 44(9):697-703. PubMed ID: 7804432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]